Evidence map›Paper›PMID 36700072›Full record

ReviewFrontiers in chemistry2022

Chemiluminescent polymeric nanoprobes for tumor diagnosis: A mini review.

Xiaoyan Zhang, Cong Li, Wenjuan Chen, Guanhua Wang, Huiru Zou, Hao Liu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaoyan ZhangCentral Laboratory, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China.
Cong LiCentral Laboratory, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China.
Wenjuan ChenCentral Laboratory, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China.
Guanhua WangCentral Laboratory, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China.
Huiru ZouCentral Laboratory, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China.
Hao LiuCentral Laboratory, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, China.
Tianjin Stomatological Hospital · CNTianjin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemiluminescence (CL), a distinct luminescent process by taking advantage of chemical reactions rather than external light source, has recently attracted considerable research interests due to its high sensitivity and low background signal. The sensitivity and specificity of chemiluminescent signals in complex tumor microenvironment provide a sound basis for accurate detection of tumors. Various chemiluminescent nanoprobes with superior performance have been obtained by structural modification of chemiluminescent units or introduction of fluorescent dyes. In this review, we focused on the recent progress of chemiluminescent polymeric systems based on various chromophore substrates, including luminol, peroxyoxalates, 1, 2-dioxetanes and their derivatives for tumor detecting. And we also emphasized the design strategies, mechanisms and diagnostic applications of representative chemiluminescent polymeric nanoprobes. Finally, the critical challenges and perspectives of chemiluminescent systems usage in tumor diagnosis were also discussed.

Indexed as

1,2-dioxetaneschemiluminescenceluminolperoxyoxalatestumor diagnosis

Identifiers

PMID36700072
PMCPMC9870064
OpenAlexW4313825934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.